Health FDA approval brings first gene therapy to the United States

tom_mai78101

The Helper Connoisseur / Ex-MineCraft Host
Staff member
The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases.

The FDA approved Kymriah (tisagenlecleucel) for certain pediatric and young adult patients with a form of acute lymphoblastic leukemia (ALL).

“We’re entering a new frontier in medical innovation with the ability to reprogram a patient’s own cells to attack a deadly cancer,” said FDA Commissioner Scott Gottlieb, M.D. “New technologies such as gene and cell therapies hold out the potential to transform medicine and create an inflection point in our ability to treat and even cure many intractable illnesses. At the FDA, we’re committed to helping expedite the development and review of groundbreaking treatments that have the potential to be life-saving.”

Kymriah, a cell-based gene therapy, is approved in the United States for the treatment of patients up to 25 years of age with B-cell precursor ALL that is refractory or in second or later relapse.

Kymriah is a genetically-modified autologous T-cell immunotherapy. Each dose of Kymriah is a customized treatment created using an individual patient’s own T-cells, a type of white blood cell known as a lymphocyte. The patient’s T-cells are collected and sent to a manufacturing center where they are genetically modified to include a new gene that contains a specific protein (a chimeric antigen receptor or CAR) that directs the T-cells to target and kill leukemia cells that have a specific antigen (CD19) on the surface. Once the cells are modified, they are infused back into the patient to kill the cancer cells.

ALL is a cancer of the bone marrow and blood, in which the body makes abnormal lymphocytes. The disease progresses quickly and is the most common childhood cancer in the U.S. The National Cancer Institute estimates that approximately 3,100 patients aged 20 and younger are diagnosed with ALL each year. ALL can be of either T- or B-cell origin, with B-cell the most common. Kymriah is approved for use in pediatric and young adult patients with B-cell ALL and is intended for patients whose cancer has not responded to or has returned after initial treatment, which occurs in an estimated 15-20 percent of patients.

Read more here. (Official FDA Press Release)
 
General chit-chat
Help Users
  • No one is chatting at the moment.
  • C Cherry.Grove:
    My boyfriend is super into Bethesda modding so I'm probably going to join him in that for a bit, then move on to making mobile/browser games.
  • C Cherry.Grove:
    I mostly just want to look at my old projects because I know I posted uploads on here somewhere.
  • C Cherry.Grove:
    My one game was basically Among Us but you sabotaged an entire medieval city simulated drastically inefficiently with dynamic NPCs :S
  • C Cherry.Grove:
    of course I never finished it x D
  • jonas jonas:
    xD
  • jonas jonas:
    I think you can still run the original game, just there's a chance your map won't work with the newer patches
  • jonas jonas:
    what development framework have you been looking at for mobile development?
  • jonas jonas:
    I'm currently creating (as a hobby) a space invaders like game for mobile using Xamarin, after starting a few larger projects that I also may not have finished :rolleyes::p
  • The Helper The Helper:
    Awesome! you should look at the Atari VCS platform it does not have a huge user base but the one it has is super active at around 11k and they have no games in there store
  • The Helper The Helper:
    basically it is linux
  • The Helper The Helper:
    OMG it is BanLord as Blackveiled on the forum
  • The Helper The Helper:
    what is up buddy
  • jonas jonas:
    thanks for the tip, that sounds cool. Never heard about the VCS before but seems like it should be a good match
  • tom_mai78101 tom_mai78101:
    The winter vacation left a toll on me. I missed staying up late and sleeping in late.
  • C Cherry.Grove:
    i haven't looked into it yet
  • C Cherry.Grove:
    If I could use something Python compatible it would save me some learning
  • C Cherry.Grove:
    But Unity might be easiest
  • C Cherry.Grove:
    looking at old posts here makes me happy. Makes me be all like "wow I was pretty smart in 2009"
  • C Cherry.Grove:
    mostly failing at life through adulthood really demotivated me for a while
  • C Cherry.Grove:
    ....what I don't get is why the fuck they would force us to permanently convert to a version of the game everyone fucking hated : \
  • C Cherry.Grove:
    Raid Shadow Legends texture pack smh
  • jonas jonas:
    Most people fail at life throughout their adulthood. Sometimes we get to learn from it. Usually it just feels like crap.
    +1
  • The Helper The Helper:
    What does not kill you makes you stronger is what they say
  • C Cherry.Grove:
    for real! :cool:

    Members online

    Affiliates

    Hive Workshop NUON Dome
    Top